IP Library Granted Patent US 8,367,315
Granted Patent B2
US 8,367,315 · App. 12/718,726 · Granted Feb 5, 2013

Inactivation of reverse transcriptases by azido-diarylpyrimidines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,315
App. No.
12/718,726
Granted
Feb 5, 2013
Kind
B2
Abstract

Azido-diarylpyrimidine (azido-DAPY) compounds, and compositions containing such compounds, are provided. In addition, methods of using azido-diarylpyrimidines to inactivate reverse transcriptases, prepare inactivated viruses, and treat or prevent viral infections are also provided.

Claims (15)

1. A compound having the formula of formula (I):

wherein R 1 , R 2 , and R 3 are independently N 3 or lower alkyl, with the proviso that at least one of R 1 , R 2 , and R 3 is N 3 .

2. The compound of claim 1 , wherein R 2 and R 3 are CH 3 and R 1 is N 3 .

3. The compound of claim 1 , wherein R 1 and R 3 are CH 3 and R 2 is N 3 .

4. The compound of claim 1 , wherein R 1 and R 2 are CH 3 and R 3 is N 3 .

5. A composition comprising:

a compound having the formula of formula (I):

wherein R 1 , R 2 , and R 3 are independently N 3 or lower alkyl, with the proviso that at least one of R 1 , R 2 , and R 3 is N 3 ; and

a pharmaceutically acceptable carrier.

6. The composition of claim 5 , wherein R 2 and R 3 are CH 3 and R 1 is N 3 .

7. The composition of claim 5 , wherein R 1 and R 3 are CH 3 and R 2 is N 3 .

8. The composition of claim 5 , wherein R 1 and R 2 are CH 3 and R 3 is N 3 .

9. The composition of claim 5 , wherein the composition is formulated as a suppository, pessary, cream, film, foam, gel, paste, or spray.

10. The composition of claim 5 , wherein the composition is formulated in a ring, sponge, or tampon.

11. The composition of claim 5 , wherein the composition comprises 0.1 to 10% by volume of the compound of formula (I).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2013
From: RIOS, ADAN
To: PHOTOIMMUNE BIOTECHNOLOGY INC.
Reel/Frame 029728/0397 →